# Manzo Pharmaceuticals, Inc. (MNZO)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/MNZO/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 60.0K | $ 7.3K | N/A | N/A | N/A |
| 2005 | $ 0 | $ -1.86M | N/A | $ 5.12M | $ -11.74M |
| 2004 | $ 0 | $ -3.11M | $ -921.1K | $ 6.52M | $ -22.50M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | -0.44 |
| Liabilities / Eq | -1.34 |
| Current Ratio | 0.20 |

## Other views

- [Metrics](https://sponda.capital/en/MNZO.md)
- [Charts](https://sponda.capital/en/MNZO/charts.md)
- [Compare](https://sponda.capital/en/MNZO/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-29.